Taghoy, Angelyn M.
HRN: 27-21-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/08/2025
CEFUROXIME 1.5GM (VIAL)
10/08/2025
10/09/2025
IV
1.5g
Q8 X3more Doses
S/P CS + IUD
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes